Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

56.65
+1.382.50%
Post-market: 56.890.2400+0.42%19:35 EDT
Volume:2.13M
Turnover:120.39M
Market Cap:10.86B
PE:20.94
High:57.81
Open:55.64
Low:55.64
Close:55.27
Loading ...
Sep 12, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
Apr 29, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2022

Major Issues Report

8-K - Current report
Feb 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 28, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities